Description

Description

Halcion (Triazolam) 0.250mg

Therapeutic indications

triazolam 0.250mg is indicated for the management of patients with transient and short-term insomnia, as well as for short-term adjunctive treatment in the management of selected patients with long-term insomnia.Halcion (Triazolam) 0.250mg

Contraindications

HALCION is contraindicated in patients with known hypersensitivity to benzodiazepines or to any component of the product formulation.

triazolam 0.250mg

Dosage and Employment Mode

It is important to individualize the dosage of HALCION tablets for a maximum beneficial effect and help avoid significant adverse effects. The recommended dose for most adults is 0.25 mg before going to sleep. It can be found that a dose of 0.125 mg is sufficient for selected patients. A dose of 0.5 mg should be reserved for those patients who do not respond adequately at a lower dose. In geriatric and/or debilitated patients, the recommended dosage range is 0.125 mg to 0.25 mg. Therapy should be started at 0.125 mg in this group. As with all medications, the lowest effective dose should be used. The safety and efficacy of HALCION have not been established in persons under 18 years of age.Halcion (Triazolam) 0.250mg